solufenum (Saren)

water-soluble salt of ibuprofen; structure in fourth source

Also Known As:

Saren; 2-(4-isobutylphenyl)lysine propionate; Arflamin; ibuprofen lysinate; ibuprofen-Lys; ibuprofenlysinate; lysine-ibuprofen; lysine-p-isobutylphenylpropionate; L-lysine, mono(alpha-methyl-4-(2-methylpropyl)benzeneacetate)

Networked: 6 relevant articles (2 outcomes, 1 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Koscova, Eva: 1 article (06/2020)
2.	Kyselovič, Ján: 1 article (06/2020)
3.	Lampert, Anette: 1 article (06/2020)
4.	Weiser, Thomas: 1 article (06/2020)
5.	Bersani, I: 1 article (01/2012)
6.	Cota, F: 1 article (01/2012)
7.	De Carolis, M P: 1 article (01/2012)
8.	De Rosa, G: 1 article (01/2012)
9.	Romagnoli, C: 1 article (01/2012)
10.	Candiani, M: 1 article (01/2001)

Related Diseases

1.	Pain (Aches) 01/01/1990 - "[Postoperative monitoring of pain under ibuprofen lysinate]." 06/01/2020 - "Ibuprofen lysinate was significantly more effective than placebo, but non-inferior to ibuprofen acid, at providing pain relief over 6 h. " 06/01/2020 - "A Randomized, Double-Blind, Placebo-Controlled Trial of Ibuprofen Lysinate in Comparison to Ibuprofen Acid for Acute Postoperative Dental Pain." 06/01/2020 - "Both active treatments significantly reduced pain compared with placebo, from 15 min post-dose to 6 h (TOTPAR: ibuprofen lysinate: 19.57; ibuprofen acid: 19.96; placebo: 8.27). "
2.	Osteoarthritis 02/01/1983 - "[Ibuprofenlysinate in the treatment of osteoarthrosis]." 11/15/1978 - "[Comparative study of the therapeutic efficacy and tolerance of lysine p-isobutylphenylpropionate and diclofenac in variously located forms of arthrosis]."
3.	Patent Ductus Arteriosus 01/01/2012 - "Ibuprofen lysinate and sodium ibuprofen for prophylaxis of patent ductus arteriosus in preterm neonates." 01/01/2012 - "This retrospective, study compared the efficacy and safety of Ibuprofen-Lysinate (Arfen, intramuscular formulation, Group I, n=156) used during 2000-2005 and Sodium-ibuprofen (Pedea, intravenous solution, Group II, n=60) used during 2006-2008, for the prophylaxis of Patent Ductus Arteriosus in inborn neonates with gestational age ≤ 28 weeks. "
4.	Body Weight (Weight, Body) 01/01/2001 - "with 5 mg ibuprofen lysinate kg(-1) body weight 1 h before embryo transfer and a control group received vehicle only. "

Related Drugs and Biologics

1.	Ibuprofen (Motrin)
2.	Acids
3.	Diclofenac (SR 38)
4.	Solutions
5.	Sodium